-
Ghana, Kenya and Malawi to Pilot Malaria Vaccine Trial
americanpharmaceuticalreview
April 27, 2017
The United Nations health agency's regional office for Africa has announced that Ghana, Kenya, and Malawi will take part in a pilot program to make the first malaria vaccine available in selected areas, beginning in 2018.
-
Serum Institute of India buys polio vaccine co in Czech for 72 mn euros
financialexpress
April 26, 2017
The acquisition would catapult the Pune-based company to the largest injectable polio vaccine maker in the world with over 200 million doses
-
Serum Institute picks up Czech vaccine factory in €72M deal
fiercepharma
April 26, 2017
Seeking to become the world's top injectable polio vaccine maker, Serum Institute of India spent €72 million to pick up a defunct outfit in the Czech Republic.
-
California immunization rates hit new highs after state law limits parental exemptions
fiercepharma
April 19, 2017
A tougher vaccine law in California that prohibits parents from using personal beliefs to exempt their kids boosted coverage rates significantly in the first school year after its implementation.
-
GSK vaccine R&D exec: Get to work now on the next emerging disease outbreak
fiercepharma
April 12, 2017
Caught off guard by deadly outbreaks such as Ebola and Zika, experts now say the current process of developing emerging-disease vaccines needs a shakeup. Here's what GlaxoSmithKline’s U.S. vaccine R&D head Ripley Ballou has in mind.
-
The first live-attenuated vaccine candidate completely protects against Zika infection
worldpharmanews
April 11, 2017
The first live-attenuated Zika vaccine still in the development stage completely protected mice against the virus after a single vaccination dose...
-
Argentina's Sinergium turns to cell-based technology for new vaccine production
fiercepharma
April 11, 2017
Argentina's Sinergium Biotech, which is in a consortium to develop a Zika virus vaccine, intends to build a new plant that will use cell biology that can be utilized for a Zika vaccine or for the flu vaccine production it already does.
-
Intent on vaccine growth, Takeda clinches massive enrollment goal in phase 3 dengue study
pharmaasia
April 07, 2017
Less than seven months after kicking off its largest vaccine trial to date, Takeda has finished enrolling 20,100 children for a mammoth phase 3 dengue study in eight endemic countries.
-
Activist parents rally in D.C., hoping Trump will change vaccine status quo
fiercepharma
April 06, 2017
Looking to push back at mandatory vaccination policies, about 150 concerned parents from around the country turned out to Washington, D.C., on Friday for a rally dubbed the Revolution for Truth.
-
KU Leuven to develop dual vaccine against yellow fever and rabies
financialexpress
April 06, 2017
The RABYD-VAX consortium, led by KU Leuven (University of Leuven, Belgium), has started developing a cheap, temperature-stable, and easy-to-produce vaccine against both diseases at once